Inventor · disambiguated record
Yaxun Yang
Also filed as: YANG YAXUN
6 granted patents·5 pending applications·8 citations·filing 2018–2024
73Inventor score
Files withFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD4MEDSHINE DISCOVERY INC3SHANDONG DANHONG PHARMACEUTICAL CO LTD3FUJIAN COSUNTER PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
11 records- 0186US11053260B2Tri-cycle compound and applications thereofFUJIAN COSUNTER PHARMACEUTICAL CO LTD·Filed 2018·Granted Jul 6, 2021·4 cites·18 claims
- 0286US11001563B2SSAO inhibitorSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2019·Granted May 11, 2021·3 cites·19 claims
- 0384US11505532B2SSAO inhibitorSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Nov 22, 2022·1 cites·9 claims
- 0481US2024287117A1Deuterated nucleoside compounds and use thereofMEDSHINE DISCOVERY INC·Filed 2024·Application pending·0 cites
- 0581US2024262837A1Deuterated nucleoside compounds and use thereofMEDSHINE DISCOVERY INC·Filed 2024·Application pending·0 cites
- 0678US2024327446A1Deuterated nucleoside compounds and use thereofMEDSHINE DISCOVERY INC·Filed 2023·Application pending·0 cites
- 0773US12116367B2Ring-modified proline short peptide compound and use thereofFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2023·Granted Oct 15, 2024·0 cites·8 claims
- 0872US2024391920A1Ring-modified proline short peptide compound and use thereofFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 0963US12077513B2Process route of compound of formula (IV), crystal form and preparation method thereforSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2019·Granted Sep 3, 2024·0 cites·16 claims
- 1062US2024158373A1Ring-modified proline short peptide compound and use thereofFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 1159US11952388B2Crystal form of tri-cycle compound and application thereofFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD·Filed 2019·Granted Apr 9, 2024·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Yaxun Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →